Bakkt Holdings
BKKT
Mawson Infrastructure
MIGI
BIT Mining
BTCM
Riot Platforms
RIOT
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
KYMR Kymera Therapeutics
- 32.540
- -0.670-2.02%
Close Mar 21 16:00 ET
- 32.540
- 0.0000.00%
Post 16:11 ET
2.11BMarket Cap-10.92P/E (TTM)
33.900High32.080Low868.20KVolume32.820Open33.210Pre Close28.43MTurnover2.03%Turnover RatioLossP/E (Static)64.94MShares53.27052wk High2.53P/B1.39BFloat Cap29.07052wk Low--Dividend TTM42.84MShs Float91.920Historical High--Div YieldTTM5.48%Amplitude9.600Historical Low32.740Avg Price1Lot Size
Kymera Therapeutics News
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chiniara Ellen
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chadwick Jeremy G
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | 8-K: Current report
Kymera Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kymera Therapeutics | 10-K: FY2024 Annual Report
Kymera Therapeutics | 8-K: Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
Kymera Therapeutics | SCHEDULE 13G/A: Others
Kymera Therapeutics | 8-K: Current report
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chiniara Ellen
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Esposito Pamela
Kymera Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Atlas Venture Fund X, L.P.(6.4%),Atlas Venture Associates X, L.P.(6.4%), etc.
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.3%)
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.